BMS-986489: This is a combination of two medications, BMS-986012 and Nivolumab, used together as a fixed dose. It is being tested to see if it can help people with extensive-stage small cell lung cancer live longer when used with chemotherapy.

Carboplatin: This is a chemotherapy medication that is used to treat various types of cancer, including lung cancer. It works by stopping the growth of cancer cells.

Etoposide: This is another chemotherapy medication used to treat lung cancer. It works by interfering with the DNA of cancer cells, preventing them from dividing and growing.

Atezolizumab: This is an immunotherapy medication that helps the immune system recognize and attack cancer cells. It is used in combination with chemotherapy to treat extensive-stage small cell lung cancer.

Extensive-Stage Small Cell Lung Cancer (ES-SCLC) – This is a type of lung cancer characterized by the rapid growth and spread of cancer cells in the lungs and potentially to other parts of the body. It is called “extensive-stage” because the cancer has spread beyond the lung to other areas, such as the opposite lung, lymph nodes, or distant organs. The disease progresses quickly, often leading to symptoms like coughing, chest pain, and difficulty breathing. As the cancer advances, it may cause additional symptoms related to the areas it has spread to, such as bone pain or neurological issues. The aggressive nature of this cancer means it can change rapidly, requiring close monitoring.